跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVT-401
首页
药物
EVT-401
EVT-401
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
EVT-401 deuterated substance and preparation method and application thereof
CN 118666747 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
EVT-401 in-vivo glucuronized metabolite M3, derivative thereof, preparation method and application thereof
CN 118666922 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
Deuterated substance of EVT-401 in-vivo metabolite M4 as well as preparation method and application of deuterated substance
CN 118666748 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
Deuterated substance of EVT-401 in-vivo metabolite M3 as well as preparation method and application of deuterated substance
CN 118666921 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
In-vivo oxidative metabolite M4 of EVT-401 medicine, analogue thereof, and preparation method and application of in-vivo oxidative metabolite M4 and analogue thereof
CN 118666749 A
申请人: ZHEJIANG JINHUA CONBA BIO PHARM CO LTD
优先权: 2024
CN
药物
反馈